MVASI (bevacizumab-awwb) recall
MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by Amgen Inc.…
Why was MVASI (bevacizumab-awwb) recalled?
Defective container: loose crimp defect, potential loss of container integrity.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: 1142258, 1143196, Exp. 09/24
- Product
- MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by Amgen Inc.…
- Recalling firm
- Amgen, Inc.
- Quantity
- 15,823
- Distribution
- Nationwide in the USA, Egypt and Lithuania.
- Recall date
- May 18, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)